Product Categories
| Country: | China |
|---|---|
| Tel: | 021-18017925 |
| Mobile: | +8618916360931 |
| E-mail: | 2596183085@qq.com |
| QQ: | 2596183085 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| RAS GTPase inhibitor 1 | C27H28ClF4N5O2 | 2252242-32-1 | Details |
| CCT020312 | C31H30Br2N4O2 | 324759-76-4 | Details |
| TA-03 | C14H16N2O | 5778-80-3 | Details |
| α-Amylase-IN-1 | C18H18N2O3 | 148404-10-8 | Details |
| BMY-14802 hydrochloride | C18H23ClF2N4O | 105565-55-7 | Details |
| Nicergoline | C24H26BrN3O3 | 27848-84-6 | Details |
| Tubulin polymerization-IN-43 | C17H13F4N3O | 2773345-90-5 | Details |
| UMB298 | C27H31ClN4O2 | 2266569-73-5 | Details |
| Suritozole | C10H10FN3S | 110623-33-1 | Details |
| Doxpicomine | C12H18N2O2 | 62904-71-6 | Details |
| IMM-H007 | C22H23N5O8 | 1221412-23-2 | Details |
| Tropanserin | C17H23NO2 | 85181-40-4 | Details |
| Rusalatide acetate (497221-38-2 free base) | C99H151N29O37S | 875455-82-6 | Details |
| Fluorogen binding modulator-1 | C16H22ClN3O5S | 510716-65-1 | Details |
| Ac-YVAD-AOM | C33H42N4O10 | 154674-81-4 | Details |
| CDC25B-IN-1 | C20H19NO3 | 2374831-10-2 | Details |
| Tiquizium | 149755-23-7 | Details |
| XL413 hydrochloride | C14H13Cl2N3O2 | 2062200-97-7 | Details |
| Methoxychlor | C16H15Cl3O2 | 72-43-5 | Details |
| Eldacimibe | C39H58N2O5 | 141993-70-6 | Details |
| WEHL-03 | C6H9N3 | 15827-80-2 | Details |
| Cyclodrine | C19H29NO3 | 52109-93-0 | Details |
| GSA-10 | C26H30N2O5 | 300833-95-8 | Details |
| 2-PCCA hydrochloride | C30H38ClN3O | 1609563-70-3 | Details |
| SB399885 | C18H21Cl2N3O4S | 402713-80-8 | Details |
| Opromazine hydrochloride | C17H19ClN2OS.ClH | 316-07-4 | Details |
| Ordopidine | C14H20FNO2S | 871351-60-9 | Details |
| Dabelotine | C15H22N2O2 | 118976-38-8 | Details |
| C-215 | C17H17Cl2N3 | 912780-51-9 | Details |
| beta-Estradiol 17-hemisuccinate | C22H28O5 | 7698-93-3 | Details |
| SR33805 | C32H40N2O5S | 121345-64-0 | Details |
| S 14506 hydrochloride | C24H27ClFN3O2 | 286369-38-8 | Details |
| Apelin-13 | C69H111N23O16S | 217082-58-1 | Details |
| ML-335 | C25H32N2O3 | 1069498-96-9 | Details |
| (E/Z)-ZINC09659342 | C23H15F3N2O4 | 591726-26-0 | Details |
| PARP-1-IN-3 | C21H17BrN2O3 | 2976342-33-1 | Details |
| Nitroaspirin | C16H13NO7 | 175033-36-0 | Details |
| L-838417 D9 | C19H19F2N7O | 1213669-91-0 | Details |
| CDD3505 | C22H17N3O2 | 173865-33-3 | Details |
| Hupehenine | C27H45NO2 | 98243-57-3 | Details |
| Chloroprocaine hydrochloride | C13H20Cl2N2O2 | 3858-89-7 | Details |
| Autotaxin-IN-3 | C22H21N9O2 | 2156655-68-2 | Details |
| Phentolamine acetate | C19H23N3O3 | 249607-96-3 | Details |
| Cimigenoside | C35H56O9 | 27994-11-2 | Details |
| SAR247799 | C21H16ClN3O5 | 1315311-14-8 | Details |
| Letaxaban | C22H26ClN3O5S | 870262-90-1 | Details |
| 2'-Hydroxy-2-methoxychalcone | C16H14O3 | 42220-77-9 | Details |
| Prifelone | C19H24O2S | 69425-13-4 | Details |
| beta-Glucogallin | C13H16O10 | 13405-60-2 | Details |
| FEMA 4774 | C19H25N3O4 | 1359963-68-0 | Details |
| Carotegrast methyl | C28H26Cl2N4O5 | 401905-67-7 | Details |
| Anticonvulsant agent 2 | C21H17ClN2 | 75220-84-7 | Details |
| Povorcitinib phosphate | C23H25F5N7O5P | 1637677-33-8 | Details |
| Ataquimast | C11H14ClN3O | 182316-31-0 | Details |
| 6-Bromo-3-methyl-1,4-dihydroquinazolin-2-one | C9H9BrN2O | 328956-24-7 | Details |
| Artemisone | C19H31NO6S | 255730-18-8 | Details |
| Adenosine receptor A1 antagonist 5 | C17H20N4O2 | 85872-53-3 | Details |
| EGFR-IN-11 | C29H35N9O2S | 2463200-44-2 | Details |
| cicloprofen | C16H14O2 | 36950-96-6 | Details |
| MMP-9-IN-6 | C25H19NO2 | 2241964-36-1 | Details |
| COX-2-IN-6 | C20H27NO6S | 2756347-91-6 | Details |
| Cymen-ar-ol | C10H14O | 39660-61-2 | Details |
| PMX 53 acetate(219639-75-5 free base) | C47H65N11O7.C2H4O2 | 852629-88-0 | Details |
| Zabicipril | C23H32N2O5 | 83059-56-7 | Details |
| P53R3 | C32H35Cl2N5O2 | 922150-12-7 | Details |
| Cyclosporine | C62H111N11O12 | 79217-60-0 | Details |
| HUP30 | C14H15N3O3S | 312747-21-0 | Details |
| PDGFR Tyrosine Kinase Inhibitor III | C27H27N5O4 | 205254-94-0 | Details |
| Xanthine dehydrogenase Inhibitor 1 | C11H7F3N4 | 80025-67-8 | Details |
| CS-B1628 | C15H19BrN2O4S | 1434643-33-0 | Details |
| Tenuifoliose J | C59H72O33 | 147742-15-2 | Details |
| 2-(5,7-dichloro-1H-indol-3-yl)ethan-1-amine | C10H10Cl2N2 | 2447-23-6 | Details |
| Gypsoside | C80H126O44 | 15588-68-8 | Details |
| CP-060 | C30H42N2O5S | 180090-15-7 | Details |
| ARC 239 dihydrochloride | C24H30ClN3O3 | 55974-42-0 | Details |
| NOX-6-18 | C18H17NO5S | 898211-21-7 | Details |
| Prolylleucine | C19H26N2O5 | 61596-47-2 | Details |
| Unedone | C13H20O4 | 1199815-09-2 | Details |
| CPUY074020 | C25H28N4O2 | 902279-44-1 | Details |
| GSK962 | C14H18N2O | 2049872-86-6 | Details |
| 4-Isopropylcatechol | C9H12O2 | 2138-43-4 | Details |
| LYN-1604 dihydrochloride | C33H44Cl3N3O2 | 2310109-38-5 | Details |
| Caudatin | C28H42O7 | 38395-02-7 | Details |
| Uk-390957 | 364321-71-1 | Details |
| PCI-27483 | C26H24N6O9S | 871266-63-6 | Details |
| Cancer-Targeting Compound 1 | C15H13N3O2S | 1007581-62-5 | Details |
| Cyanosafracin B | C29H35N5O6 | 96996-50-8 | Details |
| 1-(1-phenyltetrazol-5-yl)piperazine HCl | C11H15ClN6 | 1171471-37-6 | Details |
| Xanthopterin (hydrate) | C6H7N5O3 | 5979-01-1 | Details |
| PU-H54 | C18H19N5S | 1454619-13-6 | Details |
| SB228357 | C22H17F4N3O2 | 181629-93-6 | Details |
| Piprozolin | C14H22N2O3S | 17243-64-0 | Details |
| Anandamide | C22H37NO2 | 94421-68-8 | Details |
| JNJ-39393406 | C19H18F2N6O3 | 953428-73-4 | Details |
| MCL0020 | C34H39N7O4 | 475498-26-1 | Details |
| β-Amyloid (31-35) | C25H47N5O6S | 149385-65-9 | Details |
| CM-352 | 1542205-83-3 | Details |
| Topoisomerase II inhibitor 14 | C15H11Cl2N5 | 305343-00-4 | Details |
| CDK9-IN-7 | C29H37N7O2S | 2369981-71-3 | Details |
| Levosemotiadil | C29H32N2O6S | 116476-16-5 | Details |
| Product Total： Product Page： | ||||
| 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 | ||||